Position
Senior Vice President
Company
Nanoscope Therapeutics
DallasBiotechnologyHealth CareMedicalTherapeuticsDescription
Nanoscope Therapeutics announces the appointment of Troy Short as Senior Vice President of Manufacturing and Supply Chain. He will lead GMP manufacturing and global distribution strategies for the company's upcoming product MOGENRY™.
Quick answer
Nanoscope Therapeutics Appoints Troy Short as Senior Vice President (October 14, 2026). Nanoscope Therapeutics is based in Dallas, Texas, United States.
- Who is the new Senior Vice President at Nanoscope Therapeutics?
- Nanoscope Therapeutics named Troy Short Senior Vice President, announced October 14, 2026.
- What did Nanoscope Therapeutics announce on October 14, 2026?
- Nanoscope Therapeutics announces the appointment of Troy Short as Senior Vice President of Manufacturing and Supply Chain. He will lead GMP manufacturing and global distribution strategies for the company's upcoming product MOGENRY™.
- What does Nanoscope Therapeutics do?
- Nanoscope Therapeutics is developing mutation-agnostic, sight-restoring optogenetic therapies for the millions of patients blinded by retinal degenerative diseases for which no treatment currently exists.
- Where is Nanoscope Therapeutics based?
- Nanoscope Therapeutics is based in Dallas, Texas, United States.
- Which similar companies made leadership changes around the same time?
- Harmony Biosciences (October 13, 2026), Lobe Sciences (October 20, 2026), BioMarin Pharmaceutical (October 5, 2026) and Faeth Therapeutics (October 27, 2026) also announced leadership changes within 45 days of Nanoscope Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Peter Anastasiou Appointed as CEO of Harmony Biosciences (October 13, 2026)
- Lobe Sciences Appoints Tracy L. Goeken as Chief Medical Officer (October 20, 2026)
- BioMarin Appoints Cara Bauer as Executive Vice President, Chief People Officer (October 5, 2026)
- Faeth Therapeutics Appoints Adam Schayowitz as Class III Director (October 27, 2026)
- Pliant Therapeutics Appoints David Raben as Chief Medical Officer (September 30, 2026)
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
Who to call at Nanoscope Therapeutics, and when
A new leader at Nanoscope Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Nanoscope Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nanoscope Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nanoscope Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nanoscope Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nanoscope Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.